US Broker Ratings

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A Strong Buy with 13.23% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) has established itself as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a current market cap..

ResMed Inc. (RMD) Stock Analysis: Navigating a 7.78% Upside Potential in the Healthcare Sector

ResMed Inc. (RMD), a prominent player in the healthcare sector, has garnered investor attention with its robust market presence in the medical instruments and supplies industry. With a market capitalization..

Charles River Laboratories Inte (CRL): Analyst Consensus and Growth Potential Amidst Market Volatility

Charles River Laboratories International, Inc. (CRL) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $13.9 billion, this..

Elevance Health, Inc. (ELV) Stock Analysis: Evaluating a 10% Upside Potential

Elevance Health, Inc. (NYSE: ELV) stands as a formidable player in the healthcare plans industry, with a significant market capitalization of $88.37 billion. As a prominent health benefits company in..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 13% Potential Upside Amidst Healthcare Innovation

Doximity, Inc. (NYSE: DOCS) is a compelling player in the healthcare sector, particularly within the Health Information Services industry. With a market capitalization of $4.7 billion, Doximity is at the..

Bristol-Myers Squibb (BMY): Investor Outlook with a Focus on Dividend Yield and Strategic Collaborations

Bristol-Myers Squibb Company (NYSE: BMY), a leading player in the healthcare sector, continues to captivate investors with its robust dividend yield and strategic collaborations. As a global biopharmaceutical giant, Bristol-Myers..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Biotech Powerhouse with a Revenue Growth of 47.70%

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotechnology sector with its impressive revenue growth of 47.70%, reflecting its strong market presence and innovative approach. With a market..

The Ensign Group, Inc. (ENSG) Stock Analysis: A 28.81% Upside Potential Beckons Investors

For investors seeking opportunities in the healthcare sector, The Ensign Group, Inc. (NASDAQ: ENSG) presents a compelling case with its robust business model and significant growth potential. Operating within the..

Edwards Lifesciences (EW) Stock Analysis: Exploring a 12.3% Upside in the Medical Devices Sector

Investors in the healthcare sector are paying close attention to Edwards Lifesciences Corporation (NYSE: EW), a leading player in the medical devices industry. With a market capitalization of $51.82 billion,..

Baxter International Inc. (BAX) Stock Analysis: Exploring Potential Upside and Analyst Ratings

Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, offers a diverse portfolio of medical instruments and supplies. With a market capitalization of $13.35 billion, the company..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Exploring a 9.69% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the medical devices industry, offers an intriguing opportunity for investors looking to capitalize on growth within the healthcare sector. With..

Zoetis Inc. (ZTS) Investor Outlook: Unlocking a 26.63% Upside Potential in the Healthcare Sector

Zoetis Inc. (ZTS), a formidable player in the healthcare sector specializing in animal health, is a company that has captured the attention of investors with its robust business model and..

ICON plc (ICLR) Stock Report: Evaluating a 12.56% Potential Upside Amidst Healthcare Sector Expansion

ICON plc (NASDAQ: ICLR), a prominent player in the healthcare sector, particularly within the diagnostics and research industry, is drawing significant attention from investors. Headquartered in Dublin, Ireland, this clinical..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Discovering the 19.26% Potential Upside in Precision Oncology

Revolution Medicines, Inc. (NASDAQ: RVMD) has recently captured the attention of the investment community, not only for its groundbreaking work in the biotechnology sector but also for the significant investment..

Cardinal Health, Inc. (CAH): Investor Outlook on a Healthcare Giant with a 9.61% Potential Upside

Cardinal Health, Inc. (NYSE: CAH) stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. With a substantial market capitalization of $57.49 billion, it serves..

DaVita Inc. (DVA) Stock Analysis: Evaluating the 18.72% Upside Potential for Healthcare Investors

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specializes in providing kidney dialysis services across the United States. The company’s operations are centered around outpatient dialysis centers,..

Chemed Corp (CHE) Stock Analysis: Navigating Healthcare with Strong Revenue Growth and a 6% Upside Potential

Chemed Corp (NYSE: CHE), a notable player in the healthcare sector, operates within the medical care facilities industry in the United States. With a market capitalization of $6.79 billion, Chemed..

Stryker Corporation (SYK) Stock Analysis: Exploring a 26% Upside Potential Amidst Strong Buy Ratings

Stryker Corporation (NYSE: SYK), a prominent player in the healthcare sector, stands out in the medical devices industry with a market capitalization of $116.27 billion. Headquartered in Portage, Michigan, Stryker..

Henry Schein, Inc. (HSIC) Stock Analysis: Unveiling a 9.33% Upside Opportunity in the Medical Distribution Sector

Henry Schein, Inc. (NASDAQ: HSIC) stands at the forefront of the healthcare sector, specializing in the medical distribution industry. With a market capitalization of $10.01 billion, this Melville, New York-based..

Revvity, Inc. (RVTY) Stock Analysis: Navigating Potential in the Diagnostics Sector Amid Mixed Ratings

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, specifically within the Diagnostics & Research industry, has caught the attention of investors with its recent performance and market positioning...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds